English

China Yongxin Pharmaceuticals Inc.

EDGAR

Quarterly report (10-Q) · filed 2010-11-22

58 filing records in this dataset, filed from 2000-03-03 to 2010-11-22. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

10.5 million USD

2010-09-30 · USD

Exact inputs and evidence

Revenue: 10515586 USD Source

Operating margin

3.48%

2010-09-30 · %

Exact inputs and evidence

Operating Income: 366353 USD Source
Revenue: 10515586 USD Source

Cash and cash equivalents: 3.04 million USD 2010-06-30 Source
Exact value

3041208 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-42.2 thousand USD

2006-10-01 – 2007-09-30

Exact inputs and evidence

Operating cash flow: -27106 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: -28969 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -16628 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -19189 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -16628 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -44057 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -19189 USD · 2007-01-01 – 2007-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-11-22.

Financial data available through: 2007-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2007-12-31
Operating income: 5 of 11 periods available· newest 2007-12-31
Net income: 8 of 11 periods available· newest 2006-12-31
Operating cash flow: 8 of 11 periods available· newest 2006-12-31
capital expenditure: No compatible figures in this window
Total assets: 6 of 11 periods available· newest 2007-12-31
Total liabilities: 2 of 11 periods available· newest 2006-12-31
Current assets: 9 of 11 periods available· newest 2007-12-31
Current liabilities: 6 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+22.8%

Prior period

USD 39 million

2006-01-01 – 2006-12-31
Current period

USD 47.89 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

47892833 − 38995103 = 8897730 USD

38995103 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
47892833 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · China Yongxin Pharmaceuticals Inc. · 2007-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Year-over-year change in Revenue: 8897730 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 47892833 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001019687-08-001675.txt#3706 Input fundies:Revenue: 38995103 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001019687-08-001675.txt#3706
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 47.89 million 100% of revenue
Cost of revenue USD 39.9 million 83% of revenue
Operating expenses USD 3.88 million 8.1% of revenue
Operating income USD 4.12 million 8.6% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Not shown: operating income or net income is not reported.
2000 Not shown: operating income or net income is not reported.
2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 88%
2004 Operating loss: operating costs were 122% of revenue.
2005 Operating loss: operating costs were 1,379% of revenue.
2006 Net loss: net income was −3.2% of revenue.
2007 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	0	Unavailable	Unavailable	Unavailable	-6669	Unavailable	Source 1999-01-01 – 1999-12-31: 0 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -6669 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -6169 USD Inspect Operating Cash Flow Open source
2000 2000-01-01 – 2000-12-31	1150	Unavailable	Unavailable	Unavailable	-1381	Unavailable	Source 2000-01-01 – 2000-12-31: 1150 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -1381 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -1381 USD Inspect Operating Cash Flow Open source
2001 2001-01-01 – 2001-12-31	0	Unavailable	Unavailable	Unavailable	0	Unavailable	Source 2001-01-01 – 2001-12-31: 0 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: 0 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 0 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	6189	Unavailable	Unavailable	Unavailable	1472	Unavailable	Source 2002-01-01 – 2002-12-31: 6189 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 1472 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 452 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	4551087	4012014 Derived	539073	283709 Derived	255364	Unavailable	Source 2003-01-01 – 2003-12-31: 4551087 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 539073 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 255364 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 650429 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	3130355	3818824 Derived	-688469	5648008 Derived	-6336477	Unavailable	Source 2004-01-01 – 2004-12-31: 3130355 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -688469 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -6336477 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -479935 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	163653	2256581 Derived	-2092928	1028623 Derived	-3121551	Unavailable	Source 2005-01-01 – 2005-12-31: 163653 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -2092928 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -3121551 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -221211 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	38995103	38712095 Derived	283008	1549768 Derived	-1266760	Unavailable	Source 2006-01-01 – 2006-12-31: 38995103 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 283008 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -1266760 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -27106 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	47892833	43773954 Derived	4118879	Unavailable	Unavailable	Unavailable	Source 2007-01-01 – 2007-12-31: 47892833 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 4118879 USD Inspect Operating Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 47.9M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	0	Revenue: 0 Open source
20002000-12-31	Revenue	1150	Revenue: 1150 Open source
20012001-12-31	Revenue	0	Revenue: 0 Open source
20022002-12-31	Revenue	6189	Revenue: 6189 Open source
20032003-12-31	Revenue	4551087	Revenue: 4551087 Open source
20042004-12-31	Revenue	3130355	Revenue: 3130355 Open source
20052005-12-31	Revenue	163653	Revenue: 163653 Open source
20062006-12-31	Revenue	38995103	Revenue: 38995103 Open source
20072007-12-31	Revenue	47892833	Revenue: 47892833 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

22.8% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20002000-12-31	Year over year	No prior comparable period	Revenue: 1150 Open source Revenue: 0 Open source
20012001-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 1150 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 6189 Open source Revenue: 0 Open source
20032003-12-31	Year over year	73,435.1%	Revenue: 4551087 Open source Revenue: 6189 Open source
20042004-12-31	Year over year	-31.2%	Revenue: 3130355 Open source Revenue: 4551087 Open source
20052005-12-31	Year over year	-94.8%	Revenue: 163653 Open source Revenue: 3130355 Open source
20062006-12-31	Year over year	23,727.9%	Revenue: 38995103 Open source Revenue: 163653 Open source
20072007-12-31	Year over year	22.8%	Revenue: 47892833 Open source Revenue: 38995103 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 8.6% 2007

Net margin -3.2% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Operating margin	Not reported	Revenue: 0 Open source
2000-12-31	Operating margin	Not reported	Revenue: 1150 Open source
2001-12-31	Operating margin	Not reported	Revenue: 0 Open source
2002-12-31	Operating margin	Not reported	Revenue: 6189 Open source
20032003-12-31	Operating margin	11.8%	Operating Income: 539073 Open source Revenue: 4551087 Open source
20042004-12-31	Operating margin	-22%	Operating Income: -688469 Open source Revenue: 3130355 Open source
20052005-12-31	Operating margin	-1,278.9%	Operating Income: -2092928 Open source Revenue: 163653 Open source
20062006-12-31	Operating margin	0.7%	Operating Income: 283008 Open source Revenue: 38995103 Open source
20072007-12-31	Operating margin	8.6%	Operating Income: 4118879 Open source Revenue: 47892833 Open source
19991999-12-31	Net margin	Not reported	Net Income: -6669 Open source Revenue: 0 Open source
20002000-12-31	Net margin	-120.1%	Net Income: -1381 Open source Revenue: 1150 Open source
20012001-12-31	Net margin	Not reported	Net Income: 0 Open source Revenue: 0 Open source
20022002-12-31	Net margin	23.8%	Net Income: 1472 Open source Revenue: 6189 Open source
20032003-12-31	Net margin	5.6%	Net Income: 255364 Open source Revenue: 4551087 Open source
20042004-12-31	Net margin	-202.4%	Net Income: -6336477 Open source Revenue: 3130355 Open source
20052005-12-31	Net margin	-1,907.4%	Net Income: -3121551 Open source Revenue: 163653 Open source
20062006-12-31	Net margin	-3.2%	Net Income: -1266760 Open source Revenue: 38995103 Open source
2007-12-31	Net margin	Not reported	Revenue: 47892833 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6169 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 1150 Open source Operating Cash Flow: -1381 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 6189 Open source Operating Cash Flow: 452 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 4551087 Open source Operating Cash Flow: 650429 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 3130355 Open source Operating Cash Flow: -479935 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 163653 Open source Operating Cash Flow: -221211 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 38995103 Open source Operating Cash Flow: -27106 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 47892833 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -27.1K 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	-6169	Operating Cash Flow: -6169 Open source
20002000-12-31	Operating cash flow	-1381	Operating Cash Flow: -1381 Open source
20012001-12-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
20022002-12-31	Operating cash flow	452	Operating Cash Flow: 452 Open source
20032003-12-31	Operating cash flow	650429	Operating Cash Flow: 650429 Open source
20042004-12-31	Operating cash flow	-479935	Operating Cash Flow: -479935 Open source
20052005-12-31	Operating cash flow	-221211	Operating Cash Flow: -221211 Open source
20062006-12-31	Operating cash flow	-27106	Operating Cash Flow: -27106 Open source
20072007-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	Unavailable	Operating Cash Flow: -6169 Open source
20002000-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1381 Open source
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: 452 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: 650429 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -479935 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -221211 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -27106 Open source
20072007-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

5.7% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	Total Assets: 481 Open source
2000-12-31	Liabilities / assets	Not reported	No source recorded
2001-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	No source recorded
20032003-12-31	Liabilities / assets	64.5%	Total Liabilities: 671048 Open source Total Assets: 1039763 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 1527291 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 76465 Open source
20062006-12-31	Liabilities / assets	5.7%	Total Liabilities: 628669 Open source Total Assets: 10998827 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 22399011 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.92× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	Not reported	Current Assets: 1381 Open source Current Liabilities: 0 Open source
20002000-12-31	Current assets / current liabilities	Not reported	Current Assets: 0 Open source
20012001-12-31	Current assets / current liabilities	Not reported	Current Assets: 0 Open source
20022002-12-31	Current assets / current liabilities	Not reported	Current Assets: 1572 Open source
20032003-12-31	Current assets / current liabilities	1.29×	Current Assets: 864857 Open source Current Liabilities: 671048 Open source
20042004-12-31	Current assets / current liabilities	0.22×	Current Assets: 936216 Open source Current Liabilities: 4304123 Open source
20052005-12-31	Current assets / current liabilities	0.01×	Current Assets: 49813 Open source Current Liabilities: 5915098 Open source
20062006-12-31	Current assets / current liabilities	3.1×	Current Assets: 9825309 Open source Current Liabilities: 3168136 Open source
20072007-12-31	Current assets / current liabilities	1.92×	Current Assets: 20279230 Open source Current Liabilities: 10564632 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 6,669 Exact value Exact value: -6669 USD 1999-01-01 – 1999-12-31: -6669 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 1999-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: -6669 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6669 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001050234-02-000076.txt#1031 The citation records this snapshot. The page link may show a newer release later.	−USD 6,169 Exact value Exact value: -6169 USD 1999-01-01 – 1999-12-31: -6169 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 1999-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: -6169 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6169 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001050234-02-000076.txt#1035 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 1,381 Exact value Exact value: -1381 USD 2000-01-01 – 2000-12-31: -1381 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 2000-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: -1381 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1381 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001050234-02-000076.txt#1031 The citation records this snapshot. The page link may show a newer release later.	−USD 1,381 Exact value Exact value: -1381 USD 2000-01-01 – 2000-12-31: -1381 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 2000-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: -1381 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1381 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001050234-02-000076.txt#1035 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	USD 0 Exact value Exact value: 0 USD 2001-01-01 – 2001-12-31: 0 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 2001-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: 0 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 0 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001079372-04-000002.txt#1098 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2001-01-01 – 2001-12-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 2001-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001079372-04-000002.txt#1107 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	USD 1,472 Exact value Exact value: 1472 USD 2002-01-01 – 2002-12-31: 1472 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 2002-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: 1472 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1472 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001144204-04-005622.txt#3187 The citation records this snapshot. The page link may show a newer release later.	USD 452 Exact value Exact value: 452 USD 2002-01-01 – 2002-12-31: 452 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 2002-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: 452 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 452 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001144204-04-005622.txt#3267 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	USD 255,364 Exact value Exact value: 255364 USD 2003-01-01 – 2003-12-31: 255364 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 2003-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: 255364 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 255364 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001144204-05-016496.txt#9237 The citation records this snapshot. The page link may show a newer release later.	USD 650,429 Exact value Exact value: 650429 USD 2003-01-01 – 2003-12-31: 650429 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 2003-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: 650429 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 650429 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001144204-05-016496.txt#9866 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 6.34 million Exact value Exact value: -6336477 USD 2004-01-01 – 2004-12-31: -6336477 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 2004-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: -6336477 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6336477 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001144204-06-016026.txt#8794 The citation records this snapshot. The page link may show a newer release later.	−USD 479,935 Exact value Exact value: -479935 USD 2004-01-01 – 2004-12-31: -479935 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 2004-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: -479935 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -479935 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001144204-06-016026.txt#9262 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 3.12 million Exact value Exact value: -3121551 USD 2005-01-01 – 2005-12-31: -3121551 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 2005-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: -3121551 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3121551 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001019687-07-001084.txt#2639 The citation records this snapshot. The page link may show a newer release later.	−USD 221,211 Exact value Exact value: -221211 USD 2005-01-01 – 2005-12-31: -221211 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 2005-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: -221211 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -221211 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001019687-07-001084.txt#2662 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 1.27 million Exact value Exact value: -1266760 USD 2006-01-01 – 2006-12-31: -1266760 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Yongxin Pharmaceuticals Inc. · 2006-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Net Income: -1266760 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1266760 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001019687-07-001084.txt#2639 The citation records this snapshot. The page link may show a newer release later.	−USD 27,106 Exact value Exact value: -27106 USD 2006-01-01 – 2006-12-31: -27106 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Yongxin Pharmaceuticals Inc. · 2006-12-31 China Yongxin Pharmaceuticals Inc. (edgar:1087848) Operating Cash Flow: -27106 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1087848/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27106 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1087848/0001019687-07-001084.txt#2662 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

58 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001087848, 1087848, edgar:1087848

Also known as DIGITAL LEARNING, Digital Learning Management CO, FREEPCSQUOTE COM, Nutradyne Group, Inc., Nutradyne, Inc.

China Yongxin Pharmaceuticals Inc.

Latest quarter

Revenue

Operating margin

Trailing twelve months

Operating cash flow

Company performance

What changed year over year

Revenue

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation